<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">A recently published retrospective observational case series focused upon the neurologic manifestations of COVID-19 from Wuhan China, and included 214 consecutive hospitalized patients with laboratory-confirmed diagnosis [
 <xref rid="bb0050" ref-type="bibr">10</xref>]. This analysis showed that approximately 60% of patients were designated as having mild disease, with the remainder characterized as having severe infection, defined with respect to their respiratory status. Approximately 36% of the cohort exhibited neurological manifestations, with those designated as having more severe disease being more likely to significantly harbor comorbid conditions with hypertension being most common, as well as being significantly less likely to present with the more typical respiratory symptoms (at least at presentation) of COVID-19, such as cough in the context of fever [
 <xref rid="bb0050" ref-type="bibr">10</xref>].
</p>
